Premium
Glutamine deprivation alters the origin and function of cancer cell exosomes
Author(s) -
Fan ShihJung,
Kroeger Benjamin,
Marie Pauline P,
Bridges Esther M,
Mason John D,
McCormick Kristie,
Zois Christos E,
Sheldon Helen,
Khalid Alham Nasullah,
Johnson Errin,
Ellis Matthew,
Stefana Maria Irina,
Mendes Cláudia C,
Wainwright Stephen Mark,
Cunningham Christopher,
Hamdy Freddie C,
Morris John F,
Harris Adrian L,
Wilson Clive,
Goberdhan Deborah CI
Publication year - 2020
Publication title -
the embo journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.484
H-Index - 392
eISSN - 1460-2075
pISSN - 0261-4189
DOI - 10.15252/embj.2019103009
Subject(s) - medicine , library science , classics , history , computer science
Exosomes are secreted extracellular vesicles carrying diverse molecular cargos, which can modulate recipient cell behaviour. They are thought to derive from intraluminal vesicles formed in late endosomal multivesicular bodies ( MVB s). An alternate exosome formation mechanism, which is conserved from fly to human, is described here, with exosomes carrying unique cargos, including the GTP ase Rab11, generated in Rab11‐positive recycling endosomal MVB s. Release of Rab11‐positive exosomes from cancer cells is increased relative to late endosomal exosomes by reducing growth regulatory Akt/mechanistic Target of Rapamycin Complex 1 ( mTORC 1) signalling or depleting the key metabolic substrate glutamine, which diverts membrane flux through recycling endosomes. Vesicles produced under these conditions promote tumour cell proliferation and turnover and modulate blood vessel networks in xenograft mouse models in vivo . Their growth‐promoting activity, which is also observed in vitro , is Rab11a‐dependent, involves ERK ‐ MAPK ‐signalling and is inhibited by antibodies against amphiregulin, an EGFR ligand concentrated on these vesicles. Therefore, glutamine depletion or mTORC 1 inhibition stimulates release from Rab11a compartments of exosomes with pro‐tumorigenic functions, which we propose promote stress‐induced tumour adaptation.